財經影音專區

五年後衛諾（Wegovy）獲 FDA 核准，醫療肥胖藥物市場進入高速發展期。諾和利（Novo Nordisk）與礼隆（Eli Lilly）本年推出 GLP-1 oral 藥片，Structure Therapeutics、Zealand Pharma 等新進者爭奪市佔。在美國糖尿病協會會議上，記者 Angelica Peebles 探討了市場竞争的加剧與未来创新方向。專家預言下一波創新將聚焦於更具成本效益的口服 GLP-1 類似物以及長效注射劑。CNBC 透過《The Next Phase Of The Obesity Drug Race》深入剖析產業鏈格局與投資機會。

Starbase, Texas is SpaceX’s new company town and IPO hub.The anticipated $1.8 trillion IPO could create many new millionaires among local employees.Brownsville, historically one of the poorest U.S. cities, faces rapid economic change.Residents and local businesses are bracing for both opportunity and uncertainty.WSJ’s on‑the‑ground report explores the shifting economy and future of the region.